Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020180

« Back to Dashboard

NDA 020180 describes PROSCAR, which is a drug marketed by Merck and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the PROSCAR profile page.

The generic ingredient in PROSCAR is finasteride. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the finasteride profile page.

Summary for 020180

Tradename:	PROSCAR
Applicant:	Merck
Ingredient:	finasteride
Patents:	1
Therapeutic Class:	Genitourinary Agents Hormonal Agents, Suppressant (Sex Hormones/Modifiers)
Formulation / Manufacturing:	see details

Pharmacology for NDA: 020180

Mechanism of Action	5-alpha Reductase Inhibitors

Medical Subject Heading (MeSH) Categories for 020180

5-alpha Reductase Inhibitors
Urological Agents

Suppliers and Packaging for NDA: 020180

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
PROSCAR	finasteride	TABLET;ORAL	020180	NDA	Merck Sharp & Dohme Corp.	0006-0072	N	0006-0072-31
PROSCAR	finasteride	TABLET;ORAL	020180	NDA	Merck Sharp & Dohme Corp.	0006-0072	N	0006-0072-58

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	5MG
Approval Date:	Jun 19, 1992	TE:	AB	RLD:	Yes
Patent:	➤ Sign Up	Patent Expiration:	Oct 23, 2018	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	TREATING PRECIPITATED ACUTE URINARY RETENTION WITH FINASTERIDE

Expired US Patents for NDA 020180

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Merck	PROSCAR	finasteride	TABLET;ORAL	020180-001	Jun 19, 1992	➤ Sign Up	➤ Sign Up
Merck	PROSCAR	finasteride	TABLET;ORAL	020180-001	Jun 19, 1992	➤ Sign Up	➤ Sign Up
Merck	PROSCAR	finasteride	TABLET;ORAL	020180-001	Jun 19, 1992	➤ Sign Up	➤ Sign Up
Merck	PROSCAR	finasteride	TABLET;ORAL	020180-001	Jun 19, 1992	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.